Latest news
FibroBiologics Granted European Patent Covering Gene Therapy for the Regeneration of Cartilage - PR NewswirePR Newswire · Wed, 05 Aug 2026 12:30:00 GMTRegentis Biomaterials Advances GelrinC as Potential First-in-Class Cartilage Repair Treatment - citybuzz -citybuzz - · Tue, 04 Aug 2026 00:29:26 GMTRegentis Biomaterials (RGNT) Advances Regenerative Solution for Major Unmet Need in Cartilage Repair - NewMediaWireNewMediaWire · Mon, 03 Aug 2026 19:35:05 GMTRegentis Biomaterials (NYSE American: RGNT) Targets $3B Cartilage Repair Market with Cell-Free Gelrin C - BenzingaBenzinga · Thu, 30 Jul 2026 17:20:25 GMTRegentis Biomaterials (RGNT) Targets $3B Cartilage Repair Market with Cell-Free Gelrin C - Yahoo FinanceYahoo Finance · Thu, 30 Jul 2026 07:00:00 GMTRegentis Biomaterials (RGNT) Positioned to Benefit as Regenerative Medicine Reshapes the Growing $3B Cartilage Repair Market - Yahoo! Finance CanadaYahoo! Finance Canada · Mon, 27 Jul 2026 07:00:00 GMT